HLS Therapeutics (HLS.V) Q4 2024 Earnings

7NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.26
-0.23
-0.2
-0.17

Details

Expected EPS
-0.17314043625
Actual EPS
-0.20797649999999998
Surprise EPS
-0.03
Surprise Percent
+20.12%

Description

HLS Therapeutics (HLS.V) has reported earnings of -0.20797649999999998 per share for Q4 2024.

0 Comments

Share your thoughts